CoChat

Nephrolithiasis in Cushing’s Disease: Prevalence, Etiopathogenesis, and Modification after Disease Cure

Faggiano, Antongiulio, Pivonello, Rosario, Melis, Daniela, Filippella, Mariagiovanna, Di Somma, Carolina, Petretta, Mario, Lombardi, Gaetano, Colao, Annamaria · 2003 · The Journal of Clinical Endocrinology & Metabolism
Cited by 98

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The pathogenesis of nephrolithiasis in Cushing’s syndrome is still not completely clarified. The current study aimed at investigating prevalence of nephrolithiasis and role of different lithogenic factors in Cushing’s disease (CD). Forty-six CD patients (24 with active and 22 with cured disease) and 46 sex- and age-matched controls entered the study. Body mass index, blood pressure, fasting glucose and insulin, serum and urinary creatinine, urea, uric acid, electrolytes, and cystine, urinary volume, pH, oxalate, and citrate levels, and renal ultrasonography (US) were performed in all patients and controls. Nephrolithiasis was found in 50% of active patients, 27.3% of cured patients, and 6.5% of controls (P < 0.001). Compared with controls, patients with active disease had a significantly increased prevalence of obesity, arterial hypertension, diabetes mellitus, hypercalciuria, hypocitraturia, and hyperuricosuria, significantly higher levels of serum and urinary cystine, urinary creatinine, urea, uric acid, potassium, calcium, phosphorus, and oxalate, significantly lower levels of urinary citrate levels. Compared with controls, patients cured from CD had a significantly increased prevalence of obesity, systemic arterial hypertension, and diabetes mellitus, whereas urinary citrate was significantly decreased. At multivariate analysis, a significantly increased risk to develop kidney stones was independently associated with urinary excretion of uric acid (odds ratio = 1.6, confidence interval = 1.0–2.5) and systemic arterial blood pressure (odds ratio = 2.6, confidence interval = 1.1–6.6). In conclusion, patients with active CD have an increased prevalence of nephrolithiasis compared with general population, which decreases but not disappears in patients successfully cured from the disease. This complication is likely caused by the synergic effect of different hypercortisolism-dependent metabolic and hemodynamic abnormalities, among which systemic arterial hypertension and excessive urinary uric acid excretion seem to play a pivotal role.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2002-021494

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. Cushing, 1932, Basophil adenoma of the pituitary body and their clinical manifestations., Bull John Hopkins Hosp, 50, 137
  2. Ross, 1966, Cushing’s syndrome: diagnostic criteria., Q J Med, 35, 149
  3. Pak, 1990, Kidney stones: pathogenesis, diagnosis and therapy, 823
  4. Johnson, 1979, Renal stone epidemiology: a 25-year study in Rochester, Minnesota., Kidney Int, 16, 624, 10.1038/ki.1979.173 · DOI · Paper page
  5. Serio, 1999, Epidemiology of nephrolithiasis., Nephron, 81, 26, 10.1159/000046295 · doi:10.1159/000046295
  6. Hahn, 1979, Altered mineral metabolism in glucocorticoid-induced osteopenia., J Clin Invest, 64, 655, 10.1172/JCI109506 · DOI · Paper page
  7. Canalis, 1996, Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis., J Clin Endocrinol Metab, 81, 3441
  8. Marangella, 1999, Idiopathic calcium neprolithiasis., Nephron, 81, 38, 10.1159/000046297 · doi:10.1159/000046297
  9. Coe, 1983, Uric acid and calcium oxalate nephrolithiasis., Kidney Int, 24, 392, 10.1038/ki.1983.172 · DOI
  10. Faggiano, 2002, Evaluation of circulating levels and renal clearance of natural aminoacids in patients with Cushing’s disease., J Endocrinol Invest, 25, 142, 10.1007/BF03343978 · DOI
  11. Simon, 1993, Persistent hypertension after successful adrenal operation., Surgery, 114, 1189
  12. Colao, 1999, Persistence of increased cardiovascular risk in patients with Cushing’s disease after 5 years of successful cure., J Clin Endocrinol Metab, 84, 2664
  13. Di Somma, 1998, Effectiveness of a chronic treatment with alendronate in the osteoporosis of Cushing’s disease., Clin Endocrinol, 48, 655, 10.1046/j.1365-2265.1998.00486.x · DOI · Paper page
  14. 1983, Obesity. A report of the Royal College of Physicians., J R Coll Physicians Lond, 17, 5
  15. 1996, WHO Tech Rep Ser, 862, 1
  16. Bauer, 1982, Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate., Am J Kidney Dis, 2, 337, 10.1016/S0272-6386(82)80091-7 · DOI · Paper page
  17. Middleton, 1988, Renal calculi: sensitivity for detection with US., Radiology, 167, 239, 10.1148/radiology.167.1.3279456 · doi:10.1148/radiology.167.1.3279456
  18. Lemann Jr, 1999, Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review., Nephron, 81, 18, 10.1159/000046294 · DOI · Paper page
  19. Walker, 1972, Calcium retention in adult human male affected by protein intake., J Nutr, 102, 1297, 10.1093/jn/102.10.1297 · DOI
  20. Prié, 2001, Frequency of renal phosphate leak among patients with calcium nephrolithiasis., Kidney Int, 60, 272, 10.1046/j.1523-1755.2001.00796.x · doi:10.1046/j.1523-1755.2001.00796.x
  21. Borghi, 1999, Essential arterial hypertension and stone disease., Kidney Int, 55, 2397, 10.1046/j.1523-1755.1999.00483.x · DOI · Paper page
  22. Curhan, 2001, Twenty-four-hour urine chemistries and the risk of kidney stones among women and men., Kidney Int, 59, 2290, 10.1046/j.1523-1755.2001.00746.x · DOI · Paper page
  23. Lieske, 1999, Cell-crystal interactions and kidney stone formation., Nephron, 81, 8, 10.1159/000046293 · doi:10.1159/000046293
  24. Rubin, 1971, Serum uric acid, cholesterol, and cortisol intercorrelations in normoactive subjects., Am Heart J, 81, 843, 10.1016/0002-8703(71)90091-3 · doi:10.1016/0002-8703(71)90091-3
  25. Adams, 1968, Effect of cortisol on growth and uric acid excretion in the chick., J Endocrinol, 40, 145, 10.1677/joe.0.0400145 · doi:10.1677/joe.0.0400145
  26. Lemann Jr, 1959, The relation of sulfur metabolism to acid-base balance and eletrolyte excretion: the effects of dl-methionine in normal man., J Clin Invest, 38, 2215, 10.1172/JCI104001 · DOI

Cited by

See all 98

Metadata

Authors
Faggiano, A., Pivonello, R., Melis, D., Filippella, M., Di Somma, C., Petretta, M., Lombardi, G., & Colao, A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2003-05-01
Volume
88
Issue
5
Pages
2076-2080
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2110260815
Cited by
98
References
1
FWCI
2.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.